Application of an agr-Specific Antivirulence Compound as Therapy for Staphylococcus aureus-Induced Inflammatory Skin Disease

Abstract Atopic dermatitis (AD) is a chronic inflammatory skin disease where more than 90% of patients affected are colonized with Staphylococcus aureus. In AD, S. aureus δ-toxin is a major virulence factor causing cutaneous inflammation via mast cell degranulation. δ-toxin is controlled by the S. aureus agr quorum sensing system, and thus we addressed whether interference with agr signaling would limit skin inflammation. Indeed, treatment of S. aureus with the agr-inhibitor solonamide B (SolB) abolished δ-toxin production and reduced skin inflammation in a mouse model of inflammatory skin disease, demonstrating the potential of antivirulence therapy in treating S. aureus-induced skin disorders.

[1]  G. Núñez,et al.  Staphylococcus aureus Virulent PSMα Peptides Induce Keratinocyte Alarmin Release to Orchestrate IL-17-Dependent Skin Inflammation. , 2017, Cell host & microbe.

[2]  R. Geha,et al.  Staphylococcus aureus Epicutaneous Exposure Drives Skin Inflammation via IL-36-Mediated T Cell Responses. , 2017, Cell host & microbe.

[3]  G. Núñez,et al.  Role of the microbiota in skin immunity and atopic dermatitis. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[4]  H. Ingmer,et al.  The agr Inhibitors Solonamide B and Analogues Alter Immune Responses to Staphylococccus aureus but Do Not Exhibit Adverse Effects on Immune Cell Functions , 2016, PloS one.

[5]  J. Kahlenberg,et al.  Staphlyococcus aureus Phenol-Soluble Modulins Stimulate the Release of Proinflammatory Cytokines from Keratinocytes and Are Required for Induction of Skin Inflammation , 2015, Infection and Immunity.

[6]  Jennifer L. Martin,et al.  Targeting virulence not viability in the search for future antibacterials. , 2015, British journal of clinical pharmacology.

[7]  G. Hansen,et al.  The diagnosis and graded therapy of atopic dermatitis. , 2014, Deutsches Arzteblatt international.

[8]  Gordon Y C Cheung,et al.  Phenol-soluble modulins--critical determinants of staphylococcal virulence. , 2014, FEMS microbiology reviews.

[9]  L. Gram,et al.  Solonamide B Inhibits Quorum Sensing and Reduces Staphylococcus aureus Mediated Killing of Human Neutrophils , 2014, PloS one.

[10]  K. Cease,et al.  Staphylococcus δ-toxin induces allergic skin disease by activating mast cells , 2013, Nature.

[11]  W. Abramovits,et al.  Role of interleukin 1 in atopic dermatitis. , 2013, Dermatologic clinics.

[12]  L. French,et al.  Interrupting IL-6-receptor signaling improves atopic dermatitis but associates with bacterial superinfection. , 2011, The Journal of allergy and clinical immunology.

[13]  P. Schlievert,et al.  Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. , 2010, The Journal of allergy and clinical immunology.

[14]  A. Kennedy,et al.  Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA , 2007, Nature Medicine.

[15]  A. Conde.  Staphylococcus aureus infections. , 1998, The New England journal of medicine.